1. $INCY vs. $MDVN vs. $ALKS vs. $ISIS Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=INCY|MDVN|ALKS|ISIS|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  2. End Of Day Scan: CCI Sell Signals $MDVN $DEO $RTN $LII $HSY $GRA $CHD $ANET $ONCE $WWD

  3. $MDVN how many companies that haven t been acquired have billion dollar drugs like Xtandi. Exactly.

  4. $MDVN Revenue is Rising. Here s the Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=MDVN&financial_bar=Revenue+(TTM+US$+Millions)&financial_line=Revenue+(TTM+US$+Millions)&start_date=12/31/2008&end_date=12/31/2014&show_line=false&sk=9c3ed523eab67d1526a0bd6d46aebd35

  5. EQM Capital holds an allocation of 3.4% in $MDVN in his Mid Cap Quant Investment Portfolio

  6. $MDVN adding to ITM 2016 calls

  7. $MDVN wow investors must be shaky to get chased out by Credit Sussie comments. They have a very poor reputation in picking biotech.

  8. Analyst Up/Downgrades $ADRO $FB $LULU $MTG $NOK $SYMC $SYF $YUM $CERN $CHD $COTY $HSY $JBHT $MRO $MDVN $SLB $DATA http://247wallst.com/investing/2015/04/20/top-analyst-upgrades-and-downgrades-aduro-bio-facebook-lululemon-mgic-nokia-schlumberger-yum-and-more/

  9. This is why I didn t chase $JUNO $ONCE . I will load up once they are down 30-50% from highs. $MDVN $PCYC $GILD $ALNY all did same.

  10. $MDVN credit sussie of course good acquisition targets are a premium. Welcome to biotech and how to make money.

  11. Notable morning upgrades 4-20 - $GIS, $JBHT, $MRO, $MTG, $SYMC & Downgrades - $CERN, $HAL, $KORS, $LULU, $MDVN, $SLB, $XEC

  12. Medivation s neutral rating reiterated at Credit Suisse Group AG. $115.00 PT. http://www.analystratings.net/stocks/NASDAQ/MDVN/?RegistrationCode=SocialMedia-direct $MDVN

  13. Credit Suisse Assumes, Downgrades Medivation ($MDVN) to Neutral; Upside Driven By M&A Spec Likely ... http://www.streetinsider.com/Analyst+Comments/Credit+Suisse+Assumes%2C+Downgrades+Medivation+%28MDVN%29+to+Neutral%3B+Upside+Driven+By+M%26A+Spec+Likely+to+Fade/10470037.html?si_client=st

  14. $MDVN downgraded by Credit Suisse to Neutral

  15. Earnings announcement: $MDVN is scheduled to report quarterly earnings on Thu, May 7 2015

  16. $ARWR is going to top this list in 5 years: http://investorplace.com/2015/04/10-stocks-with-3000-plus-returns-pcyc-alxn-neu-mnst-ilmn-nflx-mdvn-gmcr-regn/view-all/ $PCYC $ABBV $JNJ $ALXN $NEU $MNST $ILMN $PCLN $NFLX $MDVN $GMCR $REGN

  17. $MDVN Bullish Pullback

  18. $MDVN one of the most undervalued Biotechs for guys..had it since low 90s..see it going to 180

  19. $INCY vs. $PCYC vs. $MDVN vs. $BMRN Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=INCY|PCYC|MDVN|BMRN|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  20. After-Hours Gainers as of 5:15 p.m.: $MDVN +2.5% $PH +2.4% $VSLR +2.2% $E +2.1% $FXCM +1.9%

  21. Insider Transaction: $MDVN Automatic Sale at $132.20 per share of 3000 shares by Officer Bierly Rick on 2015-04-15.

  22. $MDVN has to be one of the few biotechs that has delivered nothing but good news for years!

  23. Medivation CFO Rick Bierly Sells $396,600 in $MDVN http://www.analystratings.net/stocks/NASDAQ/MDVN/?RegistrationCode=SocialMedia-direct&DefaultTab=Insider

  24. Medivation s Chief Financial Officer just cashed-in 3,000 options http://www.conferencecalltranscripts.org/4/summary/?id=1618291 $MDVN

  25. $MDVN: New Insider Transaction on MDVN by Chief Financial Officer Bierly Rick: http://insideri.com/1604351_000120919115034651_0001209191-15-034651